The retinal vasculature is prone to damages, leading to serious ocular diseases including loss of vision. While angiogenic therapies are being explored as potential treatments, a significant hurdle is our inability to control the three dimensional organization of the vascular network induced by angiogenic factors to ensure proper functioning of pharmacologically induced retinal vasculature. Thus, our long term objective is to unravel mechanisms that control the spatial organization of retinal vascular beds, and in particular to investigate how components of the hypoxia signaling pathway act as spatial cues to determine the direction and position of vascular growth in the retina. These studies will be carried out in three specific aims.
Aim 1. Investigate roles of prolyl hydroxylase domain proteins in controlling retinal vascular pattern formation. PHDs negatively regulate the abundance of hypoxia inducible factors (HIFs), the latter of which are essential for angiogenesis. We hypothesize that the level of PHD activity in a tissue microenvironment determines the activity and directionality of vascular growth in its vicinity, and will test this hypothesis by generating chimeric retinas that contain micro tissue domains with PHD deficiency or overexpression.
Aim 2. Determine if HIF-la accumulation in a micro tissue domain controls the position and direction of vascular growth in nearby tissues.
Aim 3. Explore the role of VEGFR-l in defining vessel to vessel distances. VEGFR-l is produced by endothelial cells and forms tight complex with VEGF-A, a key angiogenic molecule induced by hypoxia. We propose that VEGF-A/VEGFR-1 interaction diminishes bioavailable VEGF-A near the source of VEGFR-l expression and therefore disallows the growth of more microvessels within a certain distance from an existing microvessel. This hypothesis will be tested by creating chimeric retinas that contain micro tissue domains overexpressing VEGFR-1, and assessing vascular density near such tissues. The objective of these studies is to facilitate the development of effective therapies aimed at repairing damaged retinal vascular beds and is highly consistent with the mission of the National Eye Institute (NEI).
Vascular damage in the retina is associated with a numbr of serious ocular diseases including vision loss. Studies proposed in this application are designed to enhance our understanding of molecular pathways that control the spatial organization of retinal vascular system and therefore aid the development of therapeutic methods to repair retinal blood vessels.
|Duan, Li-Juan; Takeda, Kotaro; Fong, Guo-Hua (2014) Hypoxia inducible factor-2? regulates the development of retinal astrocytic network by maintaining adequate supply of astrocyte progenitors. PLoS One 9:e84736|
|Takeda, Kotaro; Duan, Li-Juan; Takeda, Hiromi et al. (2014) Improved vascular survival and growth in the mouse model of hindlimb ischemia by a remote signaling mechanism. Am J Pathol 184:686-96|
|Duan, Li-Juan; Takeda, Kotaro; Fong, Guo-Hua (2014) Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver. Am J Pathol 184:1240-50|
|Franke, Kristin; Kalucka, Joanna; Mamlouk, Soulafa et al. (2013) HIF-1ýý is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2ýý-induced excessive erythropoiesis. Blood 121:1436-45|
|Criscimanna, Angela; Duan, Li-Juan; Rhodes, Julie A et al. (2013) PanIN-specific regulation of Wnt signaling by HIF2* during early pancreatic tumorigenesis. Cancer Res 73:4781-90|
|Adluri, Ram Sudheer; Thirunavukkarasu, Mahesh; Dunna, Nageswara Rao et al. (2011) Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1ýý transcription factor and its target genes in mice. Antioxid Redox Signal 15:1789-97|